No Detail Found!

Association of Thrombocytopenia and C-reactive Protein in COVID-19 Patients Attending a Tertiary Care Hospital

Author(s)
Shaheen Kouser Department of Pathology, Dow International Medical College, Dow University of Health Science, Karachi, Sindh-Pakistan.
Farah Fatima Abbas Department of Pathology, Dow International Medical College, Dow University of Health Science, Karachi, Sindh-Pakistan.
Nehad Khan Department of Pathology, Dow International Medical College, Dow University of Health Science, Karachi, Sindh-Pakistan.
Waqas Ahmed Farooqui Board of Advanced Studies and Research, School of Public Health, Dow University of Health Science, Karachi, Sindh-Pakistan.
Saba Kamil Department of Pathology, Dow International Medical College, Dow University of Health Science, Karachi, Sindh-Pakistan.
Ramsha Khan Department of Pathology, Dow International Medical College, Dow University of Health Science, Karachi, Sindh-Pakistan.
Abstract
OBJECTIVE: This study evaluates the frequency and relationship between Thrombocytopenia and CRP levels in Covid-19 patients. METHODOLOGY: The cross-sectional retrospective study was conducted at Dr. Ishrat ul Ebad Khan Institute of Blood Diseases from October 2021 to September 2022. Data was collected from existing data from the blood bank and hematology laboratory. C reactive protein (CRP) and complete blood count (CBC) levels were observed in Covid-19 patients. Both genders, all age groups, COVID-19 patients and patients having Thrombocytopenia and raised levels of CRP were included in this study. At the same time, other bone marrow transplant patients and other infectious diseases such as Hepatitis B, Hepatitis C, Dengue, and Malaria were excluded from this study. Statistical analysis was done by using the SPSS 20.0 version. RESULTS: Out of 844 patients, the mean age was 50 years, and the male proportion was high at 70% (n=590). Most patients, 95% (n=803) had grade 1 thrombocytopenia. The mean age was found to be higher (>50 years) in Grades 1 and 2 as compared to Grades 3 and 4, where we found (<40 years). A significant (p=0.002) mean age difference among grades was found. No significant (p=0.749) median difference in CRP among Grades were found. CONCLUSION: The current study shows that COVID-19 significantly increases C-reactive protein levels. While treating and managing the patients of COVID-19, it is essential to detect the biomarkers that can predict the severity and prognosis of this disease.
Publication Details
Page(s) 272-276
Published Journal: Journal of Liaquat University of Medical and Health Sciences, Volume: 22, Issue: 04, Year: 2023

Request the full text from PASTIC

Keywords
COVID-19, Thrombocytopenia, C-reactive protein, bleeding, Covid-19
References
Guan WJ,Ni ZY,Hu Y,Liang WH,Ou CQ,He JX . .. 2020 Apr, 10(18) : 1708-20.
Thachil J .2020 .What do monitoring platelet counts in COVID‐19 teach us. J Thrombosis Haemost, 10(8) : 2071-2.
Pavord S,Thachil J,Hunt BJ,Murphy M,Lowe G,Laffan M .2020 .Practical guidance for the management of adults with immune Thrombocytopenia during the COVID-19 pandemic. Br J Haematol, 10(6) : 1038-43.
Stasi R .2012 .. Hematology Am Soc Hematol Educ Program, 10 : 191-7.
Aster RH . .Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" Thrombocytopenia. J Clin Invest. 1966 May, 10(5) : 645-57.
Teo CP,Kueh YK . .Incidence of Thrombocytopenia in an acute care hospital. Ann Acad Med Singap, 18(4) : 379-81.
Hui P,Cook DJ,Lim W,Fraser GA,Arnold DM . .The frequency and clinical significance of Thrombocytopenia complicating critical illness: a systematic review. Chest, 10(2) : 2243-8.
Chen N,Zhou M,Dong X,Qu J,Gong F,Han Y . .Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb, 6736(20) : 30211-7.
Warusevitane A,Karunatilake D,Sim J,Smith C,Roffe C .2016 .Early diagnosis of pneumonia in severe stroke: clinical features and the diagnostic role of C-reactive protein. PLoS One, 0150269(3) : e0150269.
Lorenzo-Villalba N,Zulfiqar AA,Auburtin M,Schuhmacher MH,Meyer A,Maouche Y .2020 .Thrombocytopenia in the course of COVID-19 infection. Eur J Case Rep Intern Med, 10(6) : 001702.
Monteagudo M,Amengual MJ,Munoz L,Soler JA,Roig I,Tolosa C .2008 .Reticulated platelets as a screening test to identify thrombocytopenia aetiology. QJM, 10(7) : 549-55.
Kurata Y,Hayashi S,Kiyoi T,Kosugi S,Kashiwagi H,Honda S . .Diagnostic value of tests for reticulated platelets, plasma glycocalicin, and thrombopoietin levels for discriminating between hyperdestructive and hypoplastic Thrombocytopenia. Am J Clin Pathol, 10(5) : RAW2-64.
Gauer R,Braun MM . .. 2012 Mar, 15(6) : 612-22.
Paramjit E,Rao R,Sudhamani S,Roplekar P,Shaffi Z,Roy S. .2016 .Spectrum of Thrombocytopenia: A clinicopathological study with review of the literature. Muller J Med Sci Res, 7(2) : 121-4.
Lee Y,McKechnie T,Doumouras AG,Handler C,Eskicioglu C,Gmora S .2019 .Diagnostic value of C -reactive protein levels in postoperative infectious complications after bariatric surgery: a systematic review and meta-analysis. Obes Surg, 10(7) : 32-5.
Johns I,Moschonas KE,Medina J,Ossei-Gerning N,Kassianos G,Halcox JP . .Risk classification in primary prevention of CVD according to QRISK2 and JBS3' heart age', and prevalence of elevated high-sensitivity C reactive protein in the UK cohort of the EURIKA study. Doi, 10(2) : e000849.
Tang YW,Schmitz JE,Persing DH,Stratton CW . .Laboratory diagnosis of COVID-19: current issues and challenges. J Clin Microbiol. 2020 May, 10(6) : 20.
Bivona G,Agnello L,Ciaccio M .2021 .Biomarkers for prognosis and treatment response in COVID-19 patients. 2021 Nov, 41(6) : 540-8.
Violi F,Pastori D,Cangemi R,Pignatelli P,Loffredo L .2020 .Hypercoagulation and antithrombotic treatment in coronavirus 2019: a new challenge. Thromb Haemost, 10(06) : 949-56.
Nijsten MW,ten Duis HJ,Zijlstra JG,Porte RJ,Zwaveling JH,Paling JC . .Blunted rise in platelet count in critically ill patients is associated with worse outcome. Crit Care Med, 10(12) : 00003246-6.
Huang C,Wang Y,Li X,Ren L,Zhao J,Hu Y . .Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. 2020 Feb, 6736(20) : 30183-5.
Chan JF,Yuan S,Kok KH,To KK,Chu H,Yang J . .A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating personto-person transmission: a study of a family cluster. Lancet. 2020 Feb, 6736(20) : 30154-9.
Feng G,Zheng KI,Yan QQ,Rios RS,Targher G,Byrne CD .2020 .-19 and liver dysfunction: current insights and emergent therapeutic strategies. 2020 Mar, 00018(1) : 18-24.
0

Citations

0

Downloads

44

Views